These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15270649)

  • 21. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003.
    Macroepidemiology of Influenza Vaccination (MIV) Study Group
    Vaccine; 2005 Oct; 23(44):5133-43. PubMed ID: 16039762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems in the control of epidemic influenza by vaccination.
    Pereira MS
    Ann Clin Res; 1982 Dec; 14(5-6):220-4. PubMed ID: 7171231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herd protection against influenza.
    Glezen WP
    J Clin Virol; 2006 Dec; 37(4):237-43. PubMed ID: 17008123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of influenza vaccination in the elderly in South Africa.
    van Vuuren A; Rheeder P; Hak E
    Epidemiol Infect; 2009 Jul; 137(7):994-1002. PubMed ID: 18925986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccination in the elderly: can efficacy be enhanced?
    Ershler WB
    Geriatrics; 1988 Sep; 43(9):79-83. PubMed ID: 3044929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent changes in influenza vaccination recommendations, 2007.
    Zimmerman RK
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S12-7, C1. PubMed ID: 17270107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.
    Salleras L; Domínguez A; Pumarola T; Prat A; Marcos MA; Garrido P; Artigas R; Bau A; Brotons J; Bruna X; Català P; Carreras E; Cuadra D; Gatell A; Millet S; Oller J; Raga E
    Vaccine; 2006 Nov; 24(44-46):6638-42. PubMed ID: 16842892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
    Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
    Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health benefits, risks, and cost-effectiveness of influenza vaccination in children.
    Fleming DM; Elliot AJ
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S154-8. PubMed ID: 18955891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global state of influenza in children.
    Esposito S; Marchisio P; Principi N
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S149-53. PubMed ID: 18955890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trivalent inactivated influenza vaccine compliance rate in neonatal intensive care unit parents.
    Shah S; Caprio M
    Adv Neonatal Care; 2007 Dec; 7(6):295-8. PubMed ID: 18097211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.